Uveal Melanoma: ESMO–EURACAN Clinical Practice Guideline

esmo - This ESMO–EURACAN CPG provides key recommendations for the diagnosis, staging, treatment and follow-up for uveal melanoma. It includes percutaneous hepatic perfusion and tebentafusp as treatment options for metastatic disease, reflecting emerging evidence…

AI Summary: ESMO–EURACAN released a comprehensive clinical practice guideline for uveal melanoma covering diagnosis, staging, surveillance and systemic management. The guidance clarifies best practices for multidisciplinary care, risk stratification and therapeutic sequencing, aiming to standardize treatment and follow‑up for a rare but high‑risk ocular tumour.

#healthcare #pharmaceuticals #publichealth #oncology #cancerresearch #clinicaltrials #cancerscreening

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / esmo


Back to Top / Sat, April 4, 2026, 12:21 pm / permalink 21779 / 7 stories in 4 months /




Related Stories


ESMO issues new metastatic colorectal cancer clinical guideline / 4 months

Harold P. Freeman, patient‑navigation pioneer, dies at 93 / 6 days

Perioperative advances reshape muscle‑invasive bladder cancer care / 5 wks

Two‑year lenalidomide maintenance shows no survival penalty / 6 wks

Ovarian suppression with tamoxifen cuts recurrence in premenopausal breast cancer / 7 wks

Journal retracts study claiming morning immunotherapy benefit / 2 months

Jeremy Clarkson treated for aggressive prostate cancer, now in remission / 2 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Adolescent Health, Supply Chain, Public Health, Pediatric Oncology and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.